Top Stories
WSPOS is promoting repeated low-level red-light (RLRL) therapy in its Myopia Consensus Statement 2025 as a safe and effective treatment to slow myopia progression.
GNZÂ is launching Sightwise, a programme to educate and support glaucoma patients, improve outcomes and reduce the burden on eye departments
A unique licensing agreement with Essilor Europe places The Auckland Optotypes on the global stage
Childhood blindness and prevalence of low vision in Aotearoa are falling, according to a new study led by Dr Cheefoong Chong
